KAITLYNN ELLIS: Open Payments
NPI 1437868411 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 22 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $581 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $234 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| ConvaTec Inc. | 2 | $42 |
| Myriad Genetic Laboratories, Inc. | 2 | $40 |
| Ferring Pharmaceuticals Inc. | 1 | $37 |
| UCB, Inc. | 1 | $35 |
| UROGEN PHARMA, INC. | 1 | $29 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $28 |
| 180 Medical, Inc. | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $24 |
Products named: Axonics, AMS 700, GENTLECATH GLIDE, ORGOVYX, PROLARIS, ADSTILADRIN, Rystiggo, JELMYTO.
Industry payments across KS — which companies pay providers there.
